Go. Hjelmstad et Hl. Fields, Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell, J NEUROPHYS, 85(3), 2001, pp. 1153-1158
Microinjection of kappa -opioid receptor agonists into the nucleus accumben
s produces conditioned place aversion. While attention has focused primaril
y on the inhibition of dopamine release by kappa -receptor agonists as the
synaptic mechanism underlying this effect, recent anatomical studies have r
aised the possibility that regulation of noncatecholaminergic transmission
also contribute. We have investigated the effects of kappa -receptor activa
tion on fast excitatory synaptic transmission in an in vitro slice preparat
ion using whole cell voltage-clamp or extracellular field recordings in the
shell region of the nucleus accumbens. The kappa -receptor agonist U69593
produces a pronounced, dose-dependent inhibition of glutamatergic excitator
y postsynaptic currents (EPSCs) that can be reversed by 100 nM nor-BNI. Fur
thermore, U69593 causes an increase in the paired-pulse ratio as well as a
decrease in the frequency of spontaneous miniature events, suggesting a pre
synaptic site of action. Despite anatomical evidence for kappa -receptor lo
calization on dendritic spines of nucleus accumbens neurons, no electrophys
iological evidence of a postsynaptic effect was found. This presynaptic inh
ibition of excitatory synaptic transmission in the nucleus accumbens shell
provides a novel mechanism that may contribute to the kappa -receptor-media
ted aversion observed in intact animals.